本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cartesian Therapeutics

11.21
-0.1600-1.41%
盘后11.210.00000.00%16:57 EDT
成交量:5.24万
成交额:58.69万
市值:2.91亿
市盈率:-6.48
高:11.53
开:11.50
低:10.95
收:11.37
数据加载中...
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/04

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/28

SEC问询函

Form CORRESP - Correspondence
2024/09/27

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/21

SEC问询函

Form CORRESP - Correspondence
2024/09/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]